The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
Open accessAbstract
Polycystic ovary syndrome (PCOS) is a highly prevalent endocrine-metabolic disorder that implies various severe consequences to female health, including alarming rates of infertility. Although its exact etiology remains elusive, it is known to feature several hormonal disturbances, including hyperandrogenemia, insulin resistance (IR), and hyperinsulinemia. Insulin appears to disrupt all components of the hypothalamus-hypophysis-ovary axis, and ovarian tissue insulin resistance results in impaired metabolic signaling but intact mitogenic and steroidogenic activity, favoring hyperandrogenemia, which appears to be the main culprit of the clinical picture in PCOS. In turn, androgens may lead back to IR by increasing levels of free fatty acids and modifying muscle tissue composition and functionality, perpetuating this IR-hyperinsulinemia-hyperandrogenemia cycle. Nonobese women with PCOS showcase several differential features, with unique biochemical and hormonal profiles. Nevertheless, lean and obese patients have chronic inflammation mediating the long term cardiometabolic complications and comorbidities observed in women with PCOS, including dyslipidemia, metabolic syndrome, type 2 diabetes mellitus, and cardiovascular disease. Given these severe implications, it is important to thoroughly understand the pathophysiologic interconnections underlying PCOS, in order to provide superior therapeutic strategies and warrant improved quality of life to women with this syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712
Mascarenhas, M. N., Flaxman, S. R., Boerma, T., Vanderpoel, S., & Stevens, G. A. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001356 · Cited by 2,312
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
JACOBSON, L., & SAPOLSKY, R. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-118 · Cited by 1,739
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15693 · Cited by 1,320
Epidemiology, diagnosis, and management of polycystic ovary syndrome
Sirmans, S., & Pate, K. (2013) · Clinical Epidemiology · doi:10.2147/clep.s37559 · Cited by 1,302
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Mechanisms of leptin action and leptin resistance.
Myers, M. G., Cowley, M. A., & Münzberg, H. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100707 · Cited by 1,074
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010 · cited 1×
“Given the pivotal role IR and obesity play in the etiopathogenesis and progression of PCOS and its potential subsequent metabolic and cardiovascular complications, both should be considered essential therapeutic targets [156].”
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Apridonidze, T., Essah, P. A., Iuorno, M. J., & Nestler, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1045 · Cited by 931
Obesity, insulin resistance and free fatty acids
Boden, G. (2011) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283444b09 · Cited by 848
Obesity and the polycystic ovary syndrome
Gambineri, A., Pelusi, C., Vicennati, V, Pagotto, U., & Pasquali, R. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801994 · Cited by 836
Burger, H. G. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02985-0 · Cited by 771 · cited 1×
“can bind to the androgen receptor and promote hair follicle changes [48, 49].”
Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Ehrmann, D. A., Liljenquist, D. R., Kasza, K., Azziz, R., Legro, R. S., & Ghazzi, M. N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1329 · Cited by 703
Increased risk of depressive disorders in women with polycystic ovary syndrome
Hollinrake, E., Abreu, A., Maifeld, M., Van Voorhis, B. J., & Dokras, A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.039 · Cited by 631 · cited 1×
“[47] 103 21%”
Nestler, J. E., Jakubowicz, D. J., Falcon de Vargas, A., Brik, C., Quintero, N., & Medina, F. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4886 · Cited by 617
Leptin secretion from subcutaneous and visceral adipose tissue in women.
Van Harmelen, V, Reynisdottir, S., Eriksson, P., Thörne, A., Hoffstedt, J., Lönnqvist, F., & Arner, P. (1998) · Diabetes · doi:10.2337/diabetes.47.6.913 · Cited by 611
Acne and sebaceous gland function
Zouboulis, C. C. (2004) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2004.03.004 · Cited by 561
Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561 · cited 1×
“This differential behavior resulted in attenuated metabolic effects of insulin with normal mitogenesis [87].”
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
Escobar-Morreale, H. F., Luque-Ramírez, M., & González, F. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.11.036 · Cited by 517
Martin, S. S., Qasim, A., & Reilly, M. P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.060 · Cited by 516
González, F. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.003 · Cited by 515
Developmental origin of polycystic ovary syndrome—a hypothesis
Abbott, D., Dumesic, D., & Franks, S. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740001 · Cited by 504
Escobar-Morreale, H. F., Carmina, E., Dewailly, D., Gambineri, A., Kelestimur, F., Moghetti, P., Pugeat, M., Qiao, J., Wijeyaratne, C. N., Witchel, S. F., et al. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr042 · Cited by 494
Morales, A. J. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2854 · Cited by 455
Moran, L. J., Pasquali, R., Teede, H. J., Hoeger, K. M., & Norman, R. J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.018 · Cited by 444
Molecular control of oogenesis
Sánchez, F., & Smitz, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.013 · Cited by 429
Insulin Resistance: the Link Between Obesity and Cardiovascular Disease
Reaven, G. M. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.06.002 · Cited by 395
Yildiz, B. O., Bolour, S., Woods, K., Moore, A., & Azziz, R. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp024 · Cited by 395
Draznin, B. (2006) · Diabetes · doi:10.2337/db06-0391 · Cited by 388
Hypothalamic pathways linking energy balance and reproduction
Hill, J. W., Elmquist, J. K., & Elias, C. F. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00670.2007 · Cited by 367
Review article: The impact of obesity on reproduction in women with polycystic ovary syndrome
Pasquali, R., Gambineri, A., & Pagotto, U. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.00990.x · Cited by 359
Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome
Dokras, A., Bochner, M., Hollinrake, E., Markham, S., VanVoorhis, B., & Jagasia, D. H. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000167408.30893.6b · Cited by 353
Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)
Dunaif, A., Wu, X., Lee, A., & Diamanti-Kandarakis, E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.2.e392 · Cited by 337 · cited 1×
“The presence of INSR and IGF-1 receptors in TC, GC, and stromal cells of ovarian tissue unequivocally identifies this organ as a target of insulin activity [80], confirmed by observations of decreased steroidogenesis in TC and GC from both healthy and polycystic ovaries, following in vitro administration of both anti-…”
BackgroundIs PCOS an inflammatory process?
Duleba, A. J., & Dokras, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.023 · Cited by 327
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome
Blank, S. K., McCartney, C. R., & Marshall, J. C. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml017 · Cited by 301
An update on the role of the sebaceous gland in the pathogenesis of acne
Makrantonaki, E., Ganceviciene, R., & Zouboulis, C. C. (2011) · Dermato-Endocrinology · doi:10.4161/derm.3.1.13900 · Cited by 298
Adrenarche—physiology, biochemistry and human disease
Auchus, R. J., & Rainey, W. E. (2004) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01858.x · Cited by 296
Carmina, E., & Lobo, R. A. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.01.041 · Cited by 294
Soluble Leptin Receptor Represents the Main Leptin Binding Activity in Human Blood
Lammert, A., Kiess, W., Bottner, A., Glasow, A., & Kratzsch, J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4885 · Cited by 291
Leptin in human physiology and therapeutics
Dardeno, T. A., Chou, S. H., Moon, H.-S., Chamberland, J. P., Fiorenza, C. G., & Mantzoros, C. S. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.06.002 · Cited by 286
Polycystic ovary syndrome and its developmental origins
Dumesic, D. A., Abbott, D. H., & Padmanabhan, V. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9046-0 · Cited by 283
Obesity and PCOS: Implications for Diagnosis and Treatment
Legro, R. (2012) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1328878 · Cited by 280
The vicious circle between oxidative stress and inflammation in atherosclerosis
Hulsmans, M., & Holvoet, P. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00978.x · Cited by 271
Silfen, M. E., Denburg, M. R., Manibo, A. M., Lobo, R. A., Jaffe, R., Ferin, M., Levine, L. S., & Oberfield, S. E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030617 · Cited by 269
Sex hormone binding globulin and insulin resistance
Wallace, I. R., McKinley, M. C., Bell, P. M., & Hunter, S. J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12086 · Cited by 268
Exercise therapy in polycystic ovary syndrome: a systematic review
Harrison, C. L., Lombard, C. B., Moran, L. J., & Teede, H. J. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq045 · Cited by 267
Lagiou, P., Sandin, S., Lof, M., Trichopoulos, D., Adami, H.-O., & Weiderpass, E. (2012) · BMJ · doi:10.1136/bmj.e4026 · Cited by 254
Elting, M. W., Korsen, T. J. M., Bezemer, P. D., & Schoemaker, J. (2001) · Human Reproduction · doi:10.1093/humrep/16.3.556 · Cited by 254
Tissue physiology and pathology of aromatase
Stocco, C. (2012) · Steroids · doi:10.1016/j.steroids.2011.10.013 · Cited by 246
Alterations of insulin signaling in type 2 diabetes: A review of the current evidence from humans
Fröjdö, S., Vidal, H., & Pirola, L. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.019 · Cited by 245
Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone–binding globulin gene
Selva, D. M., Hogeveen, K. N., Innis, S. M., & Hammond, G. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32249 · Cited by 232 · cited 2×
“Although insulin and the insulin-like growth factor 1 (IGF-1) have been demonstrated unable to directly repress shbg [75], they may be key indirect mediators, as they have been associated with decreased total protein secretion in human hepatic cells [76].”
Long-term health consequences of PCOS
Wild, R. A. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.3.231 · Cited by 232
Rice, S., Christoforidis, N., Gadd, C., Nikolaou, D., Seyani, L., Donaldson, A., Margara, R., Hardy, K., & Franks, S. (2005) · Human Reproduction · doi:10.1093/humrep/deh609 · Cited by 229
The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women*
Pasquali, R., & Casimirri, F. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb01744.x · Cited by 228
The Effects of a Low-Carbohydrate, Ketogenic Diet on the Polycystic Ovary Syndrome: A Pilot Study
Mavropoulos, J. C., Yancy, W. S., Hepburn, J., & Westman, E. C. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-35 · Cited by 226
Should all women with PCOS be treated for insulin resistance?
Marshall, J. C., & Dunaif, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.036 · Cited by 217
Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans.
Chan, J. L., Matarese, G., Shetty, G. K., Raciti, P., Kelesidis, I., Aufiero, D., De Rosa, V., Perna, F., Fontana, S., & Mantzoros, C. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505429103 · Cited by 213
Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?
Pellatt, L., Rice, S., & Mason, H. D. (2010) · Reproduction · doi:10.1530/rep-09-0415 · Cited by 209
Valkenburg, O., Steegers-Theunissen, R. P. M., Smedts, H. P. M., Dallinga-Thie, G. M., Fauser, B. C. J. M., Westerveld, E. H., & Laven, J. S. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1756 · Cited by 201
The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone
De Pergola, G. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801280 · Cited by 198
Leptin Concentrations in the Polycystic Ovary Syndrome1
Mantzoros, C. S., Dunaif, A., & Flier, J. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.4017 · Cited by 194
Androgenetic Alopecia in Women
Price, V. H. (2003) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1523-1747.2003.12168.x · Cited by 192
Rodin, A., Thakkar, H., Taylor, N., & Clayton, R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402173300703 · Cited by 192
Aromatase: biologic relevance of tissue-specific expression
(2004) · Seminars in Reproductive Medicine · doi:10.1055/s-2004-823023 · Cited by 190
Ovarian Steroids: The Good, the Bad, and the Signals that Raise Them
Jamnongjit, M., & Hammes, S. R. (2006) · Cell Cycle · doi:10.4161/cc.5.11.2803 · Cited by 189
The genetics of the polycystic ovary syndrome
Urbanek, M. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0400 · Cited by 185
Corbould, A. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07070 · Cited by 184
Androgen action on human skin – from basic research to clinical significance
Zouboulis, C. C., & Degitz, K. (2004) · Experimental Dermatology · doi:10.1111/j.1600-0625.2004.00255.x · Cited by 183
Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215693 · Cited by 182
Jedel, E., Waern, M., Gustafson, D., Landen, M., Eriksson, E., Holm, G., Nilsson, L., Lind, A.-K., Janson, P. O., & Stener-Victorin, E. (2010) · Human Reproduction · doi:10.1093/humrep/dep384 · Cited by 176
Neuroendocrine dysfunction in polycystic ovary syndrome
Burt Solorzano, C. M., Beller, J. P., Abshire, M. Y., Collins, J. S., McCartney, C. R., & Marshall, J. C. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.007 · Cited by 173 · cited 1×
“In turn, hyperandrogenemia induces a decrease in feedback sensitivity to both estradiol and progesterone in gonadotropic hypothalamic cells, reinforcing GnRH and LH hypersecretion [25].”
Selective Insulin Resistance in the Polycystic Ovary Syndrome1
Book, C.-B., & Dunaif, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.6010 · Cited by 172
Xiong, Y.-L., Liang, X.-Y., Yang, X., Li, Y., & Wei, L.-N. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.07.012 · Cited by 164
Molecular mechanisms of central leptin resistance in obesity
Jung, C. H., & Kim, M.-S. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0020-y · Cited by 154
Insulin Resistance in Nonobese Patients with Polycystic Ovary Syndrome
Toprak, S., Yönem, A., Çakır, B., Güler, S., Azal, Ö., Özata, M., & Çorakçı, A. (2001) · Hormone Research in Paediatrics · doi:10.1159/000049972 · Cited by 154
Crave, J. C., Lejeune, H., Brébant, C., Baret, C., & Pugeat, M. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.4.7536204 · Cited by 153
Poehlman, E. T. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.7.2463 · Cited by 151
Bremer, A. A., & Miller, W. L. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.091 · Cited by 150
Wendelin, D. S., Pope, D. N., & Mallory, S. B. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.100 · Cited by 149
Reaven, G. M. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.12.001 · Cited by 146
Ek, I., Arner, P., Bergqvist, A., Carlström, K., & Wahrenberg, H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.4.3899 · Cited by 143
Miranda, J. J., Herrera, V., Chirinos, J. A., Gómez, L. F., Perel, P., Pichardo, R. N., González, A., Sánchez, J. R., Catterina Ferreccio, R., Aguilera, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054056 · Cited by 143
Blank, S. K., McCartney, C. R., Chhabra, S., Helm, K. D., Eagleson, C. A., Chang, R. J., & Marshall, J. C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2606 · Cited by 140
Modulation of Direct Leptin Signaling by Soluble Leptin Receptor
Yang, G., Ge, H., Boucher, A., Yu, X., & Cai, L. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0027 · Cited by 137
Tumor Necrosis Factor-α Stimulates Proliferation of Rat Ovarian Theca-Interstitial Cells1
Spaczyński, R., Arici, A. M., & Dulęba, A. J. (1999) · Biology of Reproduction · doi:10.1095/biolreprod61.4.993 · Cited by 136
Pierre, A., Peigné, M., Grynberg, M., Arouche, N., Taieb, J., Hesters, L., Gonzales, J., Picard, J., Dewailly, D., Fanchin, R. R. F., et al. (2013) · Human Reproduction · doi:10.1093/humrep/des460 · Cited by 133
Zhang, G., Garmey, J. C., & Veldhuis, P. P. (2000) · Endocrinology · doi:10.1210/endo.141.8.7595 · Cited by 127
β-Cell Function: A Key Pathological Determinant in Polycystic Ovary Syndrome
Goodarzi, M. O., Erickson, S. W., Port, S. C., Jennrich, R. I., & Korenman, S. G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1006 · Cited by 118
Ketogenic diets for weight loss: A review of their principles, safety and efficacy
Sumithran, P., & Proietto, J. (2008) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2007.11.003 · Cited by 117
Leptin and Ovarian Folliculogenesis: Implications for Ovulation Induction and ART Outcomes
Brannian, J. D., & Hansen, K. A. (2002) · Seminars in Reproductive Medicine · doi:10.1055/s-2002-32501 · Cited by 116
Evidence of leptin expression in normal and polycystic human ovaries
Löffler, S. (2001) · Molecular Human Reproduction · doi:10.1093/molehr/7.12.1143 · Cited by 116
Özdemir, S., Özdemir, M., Görkemli, H., Kıyıcı, A., & Bodur, S. (2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016340903353284 · Cited by 110
Prevalence of polycystic ovaries in women with androgenic alopecia
Cela, E., Robertson, C., Rush, K., Κousta, E., White, D. M., Wilson, H., Lyons, G., Kingsley, P., McCarthy, M. I., & Franks, S. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490439 · Cited by 110
Phenotype and Metabolic Disorders in Polycystic Ovary Syndrome
Głuszak, O., Stopińska-Głuszak, U., Glinicki, P., Kapuścińska, R., Snochowska, H., Zgliczyński, W., & Dębski, R. (2012) · ISRN Endocrinology · doi:10.5402/2012/569862 · Cited by 107
Accumulation of dietary glycotoxins in the reproductive system of normal female rats
Diamanti‐Kandarakis, E., Piperi, C., Korkolopoulou, P. A., Kandaraki, E., Levidou, G., Papalois, A. E., Patsouris, E., & Papavassiliou, A. G. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0246-6 · Cited by 105
Brittle nail syndrome: A pathogenesis-based approach with a proposed grading system
van de Kerkhof, P. C. M., Pasch, M. C., Scher, R. K., Kerscher, M. J., Gieler, U., Haneke, E., & Fleckman, P. H. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.09.002 · Cited by 104
Chazenbalk, G. D., Chen, Y.-H., Heneidi, S. G., Lee, J.-M., Pall, M., Chen, Y. I., & Azziz, R. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2377 · Cited by 97
Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome.
Mukherjee, S., & Maitra, A. (2010) · PubMed · Cited by 94
Smith, Y. R., Zubieta, J., Carmen, M. G. D., Dannals, R. F., Ravert, H. T., Zacur, H. A., & Frost, J. J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5351 · Cited by 94
TLRs, macrophages, and NK cells: Our understandings of their functions in uterus and ovary
Yang, Z., Kong, B., Mosser, D. M., & Zhang, X. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.04.024 · Cited by 93
Sekar, N., Garmey, J. C., & Veldhuis, P. P. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00203-8 · Cited by 92
Chakrabarti, J. (2013) · Annals of Medical and Health Sciences Research · doi:10.4103/2141-9248.113660 · Cited by 90
Insulin Sensitivity and β-Cell Function in Women With Polycystic Ovary Syndrome
Vrbíková, J., Bendlová, B., Hill, M., Vaňková, M., Vondra, K., & Stárka, L. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1217 · Cited by 89
Hahn, S., Tan, S., Elsenbruch, S., Quadbeck, B., Herrmann, B. L., Mann, K., & Janssen, O. E. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-870236 · Cited by 88
Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
Moran, C., Arriaga, M., Rodriguez, G., & Moran, S. (2012) · International Journal of Endocrinology · doi:10.1155/2012/317241 · Cited by 86
Hameed, S., Jayasena, C. N., & Dhillo, W. S. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0265 · Cited by 85
The cycling hair follicle as an ideal systems biology research model
Al‐Nuaimi, Y., Baier, G., Watson, R. E. B., Chuong, C., & Paus, R. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01114.x · Cited by 81
Harrison, C. L., Stepto, N. K., Hutchison, S. K., & Teede, H. J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04160.x · Cited by 80
Spritzer, P. M., Poy, M., Wiltgen, D., Mylius, L. S., & Capp, E. (2001) · Human Reproduction · doi:10.1093/humrep/16.7.1340 · Cited by 80
Dermatology of androgen-related disorders
Essah, P. A., Wickham, E. P., Nunley, J. R., & Nestler, J. E. (2006) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2006.04.004 · Cited by 80
Insulin Regulation of GnRH Gene Expression through MAP Kinase Signaling Pathways
Kim, H. H., DiVall, S. A., Deneau, R. M., & Wolfe, A. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.07.002 · Cited by 78
Powell, B. L., Haddad, L., Bennett, A. J., Gharani, N., Sovio, U., Groves, C. J., Rush, K., Goh, M. J., Conway, G. S., Ruokonen, A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2485 · Cited by 76
Ek, I. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.4.1147 · Cited by 75
Vural, P., Değirmencioğlu, S., Saral, N. Y., & Akgül, C. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.02.010 · Cited by 74
Li, X.-J., Yu, Y.-X., Liu, C.-Q., Zhang, W., Zhang, H.-J., Yan, B., Wang, L.-Y., Yang, S.-Y., & Zhang, S.-H. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03917.x · Cited by 67
Allemand, M. C., Irving, B. A., Asmann, Y. W., Klaus, K. A., Tatpati, L., Coddington, C. C., & Nair, K. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004274 · Cited by 65
Pasquali, R., & Vicennati, V. (2000) · Hormone and Metabolic Research · doi:10.1055/s-2007-978680 · Cited by 63
GRUNSTEIN, H. S., JAMES, D. E., STORLIEN, L. H., SMYTHE, G. A., & KRAEGEN, E. W. (1985) · Endocrinology · doi:10.1210/endo-116-2-604 · Cited by 62
Current perspectives of insulin resistance and polycystic ovary syndrome
Pauli, J. M., Raja-Khan, N. T., Wu, X., & Legro, R. S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03460.x · Cited by 61
Yildizhan, R., Ilhan, G. A., Yildizhan, B., Kolusari, A., Adali, E., & Bugdayci, G. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.04.073 · Cited by 60
Androgens in Polycystic Ovary Syndrome: The Role of Exercise and Diet
Giallauria, F., Palomba, S., Vigorito, C., Tafuri, M. G., Colao, A., Lombardi, G., & Orio, F. (2009) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1225258 · Cited by 60
Marcondes, J. A. M., Hayashida, S. A. Y., Barcellos, C. R. G., Rocha, M. P., Maciel, G. A. R., & Baracat, E. C. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000600012 · Cited by 58
Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
Dhindsa, G., Bhatia, R., Dhindsa, M., & Bhatia, V. (2004) · PubMed · Cited by 56
Kandaraki, E., Chatzigeorgiou, A., Piperi, C., Palioura, E., Palimeri, S., Korkolopoulou, P. A., Koutsilieris, M., & Papavassiliou, A. G. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00293 · Cited by 55
The role of the endogenous opioid system in polycystic ovary syndrome
Eyvazzadeh, A. D., Pennington, K. P., Pop‐Busui, R., Sowers, M., Zubieta, J., & Smith, Y. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.05.012 · Cited by 55
Rae, M. T., Grace, C., Hogg, K., Wilson, L. M., McHaffie, S. L., Ramaswamy, S., MacCallum, J., Connolly, F., McNeilly, A. S., & Duncan, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056263 · Cited by 54
The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology
Karkanaki, A., Vosnakis, C., & Panidis, D. (2011) · HORMONES · doi:10.14310/horm.2002.1299 · Cited by 54
Finlay, D. K., Patel, S., Dickson, L. M., Shpiro, N., Márquez, R., Rhodes, C. J., & Sutherland, C. D. (2004) · BMC Molecular Biology · doi:10.1186/1471-2199-5-15 · Cited by 53
Uno, H. (1986) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-1022494 · Cited by 53
Polycystic Ovary Syndrome and Its Differential Diagnosis
Lane, D. E. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000197817.93201.04 · Cited by 52
Sepilian, V., Crochet, J. R., & Nagamani, M. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.10.038 · Cited by 51
Hyperandrogenism in Polycystic Ovary Syndrome
Rodin, A., Thakkar, H., Taylor, N., & Clayton, R. N. (1994) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199407000-00021 · Cited by 51
Unger, J. W., & Lange, W. (1997) · Cell and Tissue Research · doi:10.1007/s004410050833 · Cited by 45
Invitti, C., Martin, M. D., Delitala, G., Veldhuis, J. D., & Cavagnini, F. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90210-4 · Cited by 41
Sivayoganathan, D., Maruthini, D., Glanville, J. M., & Balen, A. H. (2011) · Human Fertility · doi:10.3109/14647273.2011.632058 · Cited by 38
Mendonça, H. C., Montenegro, R. M., Foss, M. C., de Sá, M. F. S., & Ferriani, R. A. (2004) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2004000500015 · Cited by 34
Mounier, C., Dumas, V., & Posner, B. I. (2006) · Endocrinology · doi:10.1210/en.2005-0902 · Cited by 33
Clinical and biochemical characteristics of polycystic ovary syndrome in Croatian population.
Baldani, D. P., Škrgatić, L., Goldštajn, M. Š., Zlopaša, G., Oguić, S. K., Čanić, T., & Piljek, A. N. (2012) · PubMed · Cited by 30
Inositolphosphoglycans (IPGs) as Mediators of Insulin's Steroidogenic Actions
Nestler, J. E. (1998) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.1998.9.2-4.197 · Cited by 29
Polycystic ovary syndrome - an update.
Boyle, J. A., & Teede, H. J. (2012) · PubMed · Cited by 29
Hyperandrogenemia: pathophysiology and its role in ovulatory dysfunction in PCOS.
Diamanti‐Kandarakis, E., Papailiou, J., & Palimeri, S. (2006) · PubMed · Cited by 29
Adrenal androgens regulation and adrenopause.
Alesci, S., Koch, C. A., Bornstein, & Pacák, K. (2001) · PubMed · Cited by 26
Pancreatic beta-cells dysfunction in polycystic ovary syndrome.
Diamanti‐Kandarakis, E., Xyrafis, X., Boutzios, G., & Christakou, C. D. (2008) · PubMed · Cited by 22
Epidemiologic Behavior of Obesity in the Maracaibo City Metabolic Syndrome Prevalence Study
Bermúdez, V., Pacheco, M., Rojas, J., Córdova, E., Velázquez, R., Carrillo, D., Parra, M. G., Toledo, A., Áñez, R., Fonseca, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035392 · Cited by 21
Self-citationTao, T., Li, S., Zhao, A., Zhang, Y., & Liu, W. Y. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0340 · Cited by 21
Pancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metformin
Messer, C., Boston, R., Leroith, D., Geer, E., Miller, J. D., Messer, M., & Futterweit, W. (2012) · Endocrine Practice · doi:10.4158/ep11375.or · Cited by 16
Commentary: Polycystic ovarian disease (PCOD): a misnomer, looking for a new name.
Karoshi, M., & Okolo, S. (2004) · PubMed · Cited by 13
Comparison of HbA1c levels in obese and non-obese polycystic ovarian patients.
Ünlüer, A. N., Fındık, R. B., Sevinc, N., & Karakaya, J. (2013) · PubMed · Cited by 10
Shi, Y., Zhao, D., Zhao, J., Li, Y., Liu, H., Sun, M., & Chen, Z. (2010) · PubMed · Cited by 6
(2000) · International Journal of Obesity · doi:10.1038/sj/ijo/0801280 · Cited by 6
Polycystic Ovary Syndrome, Inflammation, and Statins: Do We Have the Right Target?
Hoeger, K. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2376 · Cited by 4
Reaven, G. M. (2008) · Cited by 4
Cited by
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
Patel, S. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.04.008 · Cited by 605
Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.001 · Cited by 557
Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
Wekker, V, van Dammen, L., Koning, A., Heida, K. Y., Painter, R. C., Limpens, J., Laven, J. S. E., Roeters van Lennep, J. E., Roseboom, T. J., & Hoek, A. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa029 · Cited by 425
Upadhyay, J., Farr, O., Perakakis, N., Ghaly, W., & Mantzoros, C. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.08.004 · Cited by 375
Metadata
- Authors
- Rojas, J., Chávez, M., Olivar, L., Rojas, M., Morillo, J., Mejías, J., Calvo, M., & Bermúdez, V.
- Venue
- International Journal of Reproductive Medicine
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-17
- ISSN
- 2314-5757 (ISSN-L)
- 2356-7104
- OpenAlex
- W2067082722
- Cited by
- 467
- References
- 160
- FWCI
- 15.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.